The United States Patent and Trademark Office (USPTO) has granted Raytelligence the U.S. Patent Number 15/781,594 entitled "RADAR DETECTOR FOR MONITORING OF BODILY FUNCTIONS". The USPTO is the federal agency for granting patents and registering trademarks in the USA and the patent gives the company exclusive rights to the patented technology on the American market for the coming 20 years.
"North America is an important market for us and thus we are happy to also have our first patent approved here. This patent is also a proof that parts of our core technology is so innovative that it can be protected. This paten protects important parts of our technical strategy to provide unique products and system for the elderly care on a global market. We invest a lot in R&D and continuously also work on the protection of our innovations in a systematic way, this shows that our hard work has paid off. We also have an ongoing patent application for EU", says Klas Arvidson, CEO at Raytelligence
Questions are referred to:
Peter Martinson, CFO Raytelligence
+46 70 814 64 65
Raytelligence AB discloses the information provided herein pursuant to the Market Abuse Regulation ((EU) No 596/2014, "MAR"). The information was submitted for publication by the aforementioned person on 30 July 2021 at 11.00 (CET).
Raytelligence AB (publ)
302 42 Halmstad
About Raytelligence AB (publ)
Raytelligence is a Swedish innovation company, based in Halmstad that offers products for monitoring vital parameters, i.e., breathing, heart rate and movement patterns, based on the company's own 60 GHz radar technology.
Press releases and report by E-mail.